NSE · Healthcare · Medical Care Facilities
EPS came in at 1.72 against a street estimate of 7.20 — a miss of 76.1%.
with an average price target of ₹322.17.
MIXED Q2 was strong, with revenue up 16% YoY and Dombivli nearing EBITDA breakeven. Expansion remains on track, but management offered no financial guidance and highlighted regulatory, seasonal and ramp-up uncertainties. Q2 FY26 Dombivli lacks broad cashless insurance empanelment; management expects insurance processes to take about a year, while GIPSA may occur earlier. Analysts focused on Dombivli’s unusually sharp improvement, regulatory pricing risks, expansion funding and insurance empanelment. Management attributed performance to organic ramp-up plus seasonality, declined to quantify unmodeled impacts, and maintained conservative expectations. 2026-10-26…
Full summary in the app.
| Holder | Stake |
|---|---|
| SBI Healthcare Opportunities Fund | 7.43% |
| HDFC Mutual Fund - HDFC Multi Cap Fund | 3.46% |
| JM Financial Products | 3.42% |
| Goldman Sachs Funds - Goldman Sachs India Equity P | 2.75% |
| Mihir Wire Industries | 2.15% |
| Document | Date |
|---|---|
| Q1 FY27 earnings call JUPITER LIFE LINE HOSPITALS LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Total Income: INR 411 crores • EBITDA: INR 79.3 crores (margin: 19.3%) • PA | 2026-08-07 |
| Investor presentation JUPITER LIFE LINE HOSPITALS LIMITED – Q1 FY27 INVESTOR SUMMARY HEADLINE NUMBERS • Total Income: Rs 411.0 crore (Q1FY27) vs Rs 352.9 crore (Q1FY26) – | 2026-07-31 |
| Annual report FY2026 JUPITER LIFE LINE HOSPITALS LIMITED – ANNUAL REPORT 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from Operations (FY 2025-26): ₹1,499.78 crore (15% CA | 2026-06-22 |
| Q4 FY26 earnings call JUPITER LIFE LINE HOSPITALS LIMITED – Q4 & FY26 SUMMARY HEADLINE NUMBERS • Total Income FY26: INR 1,499.8 crores, up 15.2% year-on-year • EBITDA FY2 | 2026-05-21 |
| Investor presentation · Q4 FY26 JUPITER LIFE LINE HOSPITALS LIMITED - INVESTOR SUMMARY Q4 & FY26 Results Presentation --- HEADLINE NUMBERS • Total Income FY26: Rs 1,499.8 Cr (up 1 | 2026-05-15 |
| Q3 FY26 earnings call JUPITER LIFE LINE HOSPITALS LIMITED – Q3 & 9M FY26 SUMMARY HEADLINE NUMBERS • Q3 FY26 Total Income: INR 365.3 crores (+9.8% YoY) • Q3 EBITDA: INR 83 | 2026-02-05 |
| Investor presentation JUPITER LIFE LINE HOSPITALS LIMITED - Q3 & 9M FY26 SUMMARY HEADLINE NUMBERS • Q3FY26 Total Income: Rs 365.3 crore (up 9.8% YoY from Rs 332.8 crore i | 2026-01-31 |
| Investor presentation | 2026-01-30 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Split | ₹10 → ₹2 ex-date Jul 24, 2026 | 2026-07-24 |
| Dividend | ₹1 / share ex-date May 22, 2026 | 2026-05-22 |
| Announcement | Date |
|---|---|
| Received land lease allotment order from MMRDA The company has received formal acceptance from the Mumbai Metropolitan Region Development Authority (MMRDA) for its tender bid to lease land. This means the company's proposal to lease a pl | 2026-03-27 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Jupiter Life Line Hospitals Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.